Human Genome Epidemiology Literature Finder
Records 1 - 9 (of 9 Records) |
Query Trace: Disease Progression and FGFR3[original query] |
---|
Retrospective study testing next generation sequencing of selected cancer-associated genes in resected prostate cancer. Oncotarget 2016 Feb . Iacono Marco Lo, Buttigliero Consuelo, Monica Valentina, Bollito Enrico, Garrou Diletta, Cappia Susanna, Rapa Ida, Vignani Francesca, Bertaglia Valentina, Fiori Cristian, Papotti Mauro, Volante Marco, Scagliotti Giorgio V, Porpiglia Francesco, Tucci Marcel |
Expression levels of FGFR3 as a prognostic marker for the progression of primary pT1 bladder cancer and its association with mutation status. Oncology letters 2017 Sep 14 (3): 3817-3824. Kang Ho Won, Kim Ye-Hwan, Jeong Pildu, Park Cheol, Kim Won Tae, Ryu Dong Hee, Cha Eun-Jong, Ha Yun-Sok, Kim Tae-Hwan, Kwon Tae Gyun, Moon Sung-Kwon, Choi Yung Hyun, Yun Seok-Joong, Kim Wun-J |
Liquid Biopsy Analysis of FGFR3 and PIK3CA Hotspot Mutations for Disease Surveillance in Bladder Cancer. European urology 2017 1 71 (6): 961-969. Christensen Emil, Birkenkamp-Demtröder Karin, Nordentoft Iver, Høyer Søren, van der Keur Kirstin, van Kessel Kim, Zwarthoff Ellen, Agerbæk Mads, Ørntoft Torben Falck, Jensen Jørgen Bjerggaard, Dyrskjøt La |
NGS-based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment. Molecular oncology 2021 May . Sánchez-Herrero Estela, Serna-Blasco Roberto, Ivanchuk Vadym, García-Campelo Rosario, Dómine Gómez Manuel, Sánchez José M, Massutí Bartomeu, Reguart Noemi, Camps Carlos, Sanz-Moreno Sandra, Calabuig-Fariñas Silvia, Jantus-Lewintre Eloísa, Arnal Magdalena, Fernández-Orth Dietmar, Calvo Virginia, González-Rumayor Víctor, Provencio Mariano, Romero Atoc |
AhRR methylation contributes to disease progression in urothelial bladder cancer. Cancer biomarkers : section A of Disease markers 2022 9 35 (2): 167-177. El-Haddad Nataly W, El Kawak Michelle, El Asmar Khalil, Jabbour Michel E, Moussa Mohamad A, Habib Rima R, Dhaini Hassan |
Genetic correlation of crizotinib efficacy and resistance in ALK- rearranged non-small-cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2022 7 171 18-25. Liu Chang, Liu Cuicui, Liao Jiatao, Yin Jiani C, Wu Xianghua, Zhao Xinmin, Sun Si, Wang Huijie, Hu Zhihuang, Zhang Yao, Yu Hui, Shao Yang, Wang Jial |
Real-world data of pyrotinib-based therapy for patients with brain metastases of HER2-positive advanced breast cancer: a single-center retrospective analysis and molecular portraits. Frontiers in oncology 2023 7 13 1105474. Hui Wang, Qiaoyan Liu, Mi Zhang, Juan Zhang, Ran Ran, Yingying Ma, Jiao Yang, Fan Wang, Shujuan He, Xiaoai Zhao, Le Wang, Lingxiao Zhang, Danfeng Dong, Jin Ya |
Genomic landscape and survival analysis of ctDNA "neo-RAS wild-type" patients with originally RAS mutant metastatic colorectal cancer. Frontiers in oncology 2023 4 13 1160673. Nicolazzo Chiara, Magri Valentina, Marino Luca, Belardinilli Francesca, Di Nicolantonio Federica, De Renzi Gianluigi, Caponnetto Salvatore, De Meo Michela, Giannini Giuseppe, Santini Daniele, Cortesi Enrico, Gazzaniga Pao |
The TT Genotype of the KIAA1524 rs2278911 Polymorphism Is Associated with Poor Prognosis in Multiple Myeloma. Cells 2023 4 12 (7): . Szudy-Szczyrek Aneta, Mlak Rados?aw, Mazurek Marcin, Krajka Tomasz, Chocholska Sylwia, Bitkowska Paulina, Jutrzenka Marta, Szczyrek Micha?, Homa-Mlak Iwona, Krajka Andrzej, Ma?ecka-Massalska Teresa, Hus Mar |
- Page last reviewed:Feb 1, 2024
- Content source: